Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LINC00545 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LEF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RARRES1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CD1D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHAG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXCUT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCR10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNRC18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCEMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01122 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX3Y - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01482 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDRT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK32A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on